This week the headline appeared to have some tough news for RNA companies, but Alnylam remains undeterred about the potential of its treatments.» Read More
The effects of Obamacare will be difficult to measure as the Census Bureau is changing its annual survey. NYT reports.
CEO John Chen talks about BlackBerry's new health-care tech deal and how it plays into one of the company's core strategies.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend.
A man may have been allowed to use an electronic cigarette on a flights from Calgary to Toronto.
The London Fire Brigade has warned on the risks of e-cigarettes after one device apparently exploded and caused a fire.
US budget deficits over the next decade will be $286 billion less than previously estimated, the Congressional Budget Office said on Monday.
Shares of Biogen Idec, Celgene, Gilead Sciences, and Lexicon Pharmaceuticals recovered from last week's selloff.
GlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday.
Outgoing health secretary Kathleen Sebelius's goodbye at the White House featured one last flub—a page that vanished from her prepared remarks.
A massive dump of data about Medicare reimbursements to physicians raised eyebrows for the millions paid to some doctors, but the data aren't perfect.
Her resignation comes just days after the initial enrollment period for Obamacare ended.
Releasing data about Medicare reimbursements to doctors could have led to cost savings in the past, but legal rulings kept it hidden for 35 years.
More than 7.5 million people are expected to sign up for private health coverage this year, surpassing the 7.1 million announced last week.
The U.K. and U.S. governments spent millions stockpiling a flu drug that is no better than paracetamol, according to a new report.
Early enrollees in health exchanges were more likely to face serious health problems than those who get coverage through their employer, NYT reports.
Philadelphia's high hospital admission rate is being eyed by a new health-care joint venture as an opportunity for profit.
Following a rare look into Medicare payments, one South Florida ophthalmologist has emerged as Medicare's highest-paid individual doctor.
A tiny fraction of doctors and other health care providers who take Medicare accounted for nearly a quarter of the roughly $77 billion paid out to them under the federal program.
A massive prescription database is hoping it can introduce clarity and transparency to the prescription drugs market.
Get the best of CNBC in your inbox